Mark A Myers, MD | |
1741 Midland Trl, Shelbyville, KY 40065-1711 | |
(502) 633-0192 | |
(502) 633-4164 |
Full Name | Mark A Myers |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 35 Years |
Location | 1741 Midland Trl, Shelbyville, Kentucky |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467456855 | NPI | - | NPPES |
122601 | Other | KY | CHA |
5134693001 | Other | KY | CIGNA |
5344332 | Other | KY | AETNA |
64326192 | Medicaid | KY | |
PASSPORT ADVANTAGE | Other | KY | 2434349000 |
000000041773 | Other | KY | ANTHEM |
000802487 | Other | KY | HUMANA |
1063266 | Other | KY | PASSPORT HEALTH PLAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207XS0117X | Orthopaedic Surgery - Orthopaedic Surgery Of The Spine | 32619 (Kentucky) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Jewish Hospital - Shelbyville | Shelbyville, KY | Hospital |
Frankfort Regional Medical Center | Frankfort, KY | Hospital |
Entity Name | Bluegrass Spine Care, Psc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982755682 PECOS PAC ID: 4082512744 Enrollment ID: O20101115001245 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental New Drug Application (sNDA) for DEFINITY® (Perflutren Lipid Microsphere) Injectable Suspension for use in stress echocardiography.
The first detailed search of breast cancer genomes to uncover genomic rearrangements is published today. The team characterised the ways in which the human genome is broken and put back together in 24 cases of breast cancer.
Peregrine Pharmaceuticals, Inc. has announced that results from a Phase I clinical trial of its lead anti-phosphatidylserine (anti-PS) antibody bavituximab in combination with chemotherapy in patients with advanced cancer were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.
A trial led by a McMaster University respirology professor shows promising results for a new medicine for severe asthma patients.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Mark A Myers, MD 18 Village Plaza, Pmb 136, Shelbyville, KY 40065-1711 Ph: (502) 633-0192 | Mark A Myers, MD 1741 Midland Trl, Shelbyville, KY 40065-1711 Ph: (502) 633-0192 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental New Drug Application (sNDA) for DEFINITY® (Perflutren Lipid Microsphere) Injectable Suspension for use in stress echocardiography.
The first detailed search of breast cancer genomes to uncover genomic rearrangements is published today. The team characterised the ways in which the human genome is broken and put back together in 24 cases of breast cancer.
Peregrine Pharmaceuticals, Inc. has announced that results from a Phase I clinical trial of its lead anti-phosphatidylserine (anti-PS) antibody bavituximab in combination with chemotherapy in patients with advanced cancer were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.
A trial led by a McMaster University respirology professor shows promising results for a new medicine for severe asthma patients.
› Verified 8 days ago
Dr. John T Mahan, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1741 Midland Trl, Shelbyville, KY 40065 Phone: 502-633-0192 Fax: 502-633-0192 | |
Dr. Andrew Richard Duffee, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Stonecrest Rd, Suite 2, Shelbyville, KY 40065 Phone: 502-647-7708 Fax: 502-647-7747 |